Cardlytics (CDLX) EBT (2017 - 2026)

Cardlytics has reported EBT for 10 years, with the latest figure at -$13.8 million in Q1 2026.

• For the quarter ending Q1 2026, EBT fell 33.73% year-over-year to -$13.8 million; the trailing twelve-month figure through Mar 2026 stood at -$104.0 million (up 40.69% YoY), and the FY2025 full-year result was -$103.5 million, up 45.33% from the prior year.
• EBT for Q1 2026 stood at -$13.8 million, down from -$8.2 million in the prior quarter.
• The five-year high for EBT was $33.0 million in Q1 2022, with the low at -$378.3 million in Q4 2022.
• Historically, EBT has averaged -$53.2 million across 5 years, with a median of -$15.6 million in 2024.
• The largest YoY upside for EBT was 232.71% in 2022 against a maximum downside of 1820.3% in 2022.
• Cardlytics' EBT stood at -$378.3 million in 2022, then jumped by 73.34% to -$100.8 million in 2023, then jumped by 84.54% to -$15.6 million in 2024, then surged by 47.08% to -$8.2 million in 2025, then tumbled by 67.25% to -$13.8 million in 2026.
• The last three EBT figures came in at -$13.8 million (Q1 2026), -$8.2 million (Q4 2025), and -$72.7 million (Q3 2025), per Business Quant data.